Shares of Eli Lilly & Co. LLY rose 1.19% to $786.92 Wednesday, on what proved to be an all-around great trading session for ...

Only the U.S., China, Germany, India and Japan had larger 2024 gross domestic products than Nvidia’s market value, according ...

At last year’s inaugural “Famous Hoosiers” program Richard Gunderman made a moving and very well received presentation about ...

The FDA will allow a new dosing schedule for Eli Lilly’s Alzheimer’s drug Kisunla that could lessen a known side effect of ...

The symptoms can include nerve pain, emotional numbness and sexual dysfunction and can last for years after stopping the ...

While Eli Lilly has struggled in the past year due to competitive pressures, the statistical winds may finally favor LLY ...

Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...

Although anti-calcitonin gene-related peptides are safe and efficacious for adolescents with chronic migraine, access to treatment is often subject to extended insurance authorization delays, ...

The Vanguard Mega Cap Growth ETF tracks the CRSP U.S. Mega Cap Growth Index, which invests in the top 70% of the cumulative market capitalization of the CRSP U.S. Total Market Index. The CRSP U.S.

These 2025 high school graduates can look back with pride and forward with confidence, as we salute them in our annual ...

Lilly’s FRα targeting ADC is composed of an Fc-silent, FRα specific humanized monoclonal antibody linked to exatecan, a topoisomerase I inhibitor, via a proprietary cleavable polysarcosine linker.